Study to Investigate the Safety and Pharmacokinetic Characteristics of LC28-0126 in Healthy Male Subjects

NCT01737424 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

89

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LC28-0126
DRUG: Placebo

Sponsor

LG Life Sciences